Investors and Strategic Partners
The National Institute on Drug Abuse (NIDA)’s is interested in connecting applicants and SBIR- and STTR-funded companies with potential investors and strategic partners to continue the research and commercialization efforts towards making an impact in the opioid epidemic.
To help facilitate the connection, NIDA SBIR have come up with different strategies to provide companies with a platform to present their technologies to interested third party investors. This includes NIDA funded companies receiving supplement support to present at one industry hosted investor showcases and getting introductions to external investors that we network with at many events.
Showcases in which the NIH SBIR program has participated in the past or is considering in the future include but are not limited to:
- Angel Capital Association Annual Meeting
- AdvaMed Annual Meeting
- BIO Annual Meeting
- BIO Investor Forum
- Bionetwork East
- Bionetwork West
- Redefining Early Stage Investments (RESI Conference)
- Life Science Summit
- Precision Medicine World Conference
- BioTech Showcase
- YoungStartup Ventures
) means that you are leaving the NIH SBIR/STTR website. Such external links provide additional information that is consistent with the intended purpose of this site. The NIH SBIR/STTR program cannot attest to the accuracy of a non NIH SBIR/STTR webpages.